Literature DB >> 27123121

Cyst fluid hemoglobin species in endometriosis and its malignant transformation: The role of metallobiology.

Takuya Iwabuchi1, Chiharu Yoshimoto2, Hiroshi Shigetomi2, Hiroshi Kobayashi2.   

Abstract

The aim of the present study was to assess the relative concentrations of hemoglobin (Hb) species in endometriosis as a possible indicator of malignancy. Electronic absorption spectroscopy was employed to quantify the Hb species present in the cyst fluid collected from 8 patients with endometriosis-associated ovarian cancer (EAOC), and compared with those present in the cyst fluid of 35 patients with benign endometriotic cysts. The 620/580 nm ratio in the electronic absorption spectrum, which was used as a surrogate indicator of the methemoglobin (metHb)/(oxyhemoglobin+metHb) ratio, was measured in each cyst fluid by ultraviolet/visible grating spectrophotometric microplate reader. The optimal cutoff value was defined according to the analysis of receiver operating characteristic (ROC) curve. The sensitivity and specificity of detection were calculated on the basis of the cutoff value to differentiate EAOC from endometriosis. The 620/580 nm ratio of cyst fluid in EAOC patients was much lower than that measured in women with benign cysts (0.389±0.266 vs. 0.666±0.188, P=0.021). ROC curve analysis performed using 0.35 as the optimal cutoff value indicated that the 620/580 nm ratio had a sensitivity, specificity, positive predictive value (PPV) and negative predictive value of 62.5, 100.0, 100.0 and 92.1%, respectively, in the diagnosis of EAOC. In conclusion, metHb is one of the most abundant Hb species in benign cysts, and the absorption 620/580 nm ratio of cyst fluid exhibits high specificity and PPV as a surveillance test for the early detection of malignant transformation of endometriosis. Thus, metallobiology highlights diverse features involved in Hb homeostasis and the pathogenesis of malignant transformation of endometriosis.

Entities:  

Keywords:  endometriosis; iron; malignant transformation; methemoglobin; oxyhemoglobin

Year:  2016        PMID: 27123121      PMCID: PMC4841012          DOI: 10.3892/ol.2016.4383

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Induction of oxidative stress and oxidative damage in rat glial cells by acrylonitrile.

Authors:  L M Kamendulis; J Jiang; Y Xu; J E Klaunig
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

2.  Declaration of Helsinki revised.

Authors:  T Reynolds
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

3.  Absorption spectra of human fetal and adult oxyhemoglobin, de-oxyhemoglobin, carboxyhemoglobin, and methemoglobin.

Authors:  W G Zijlstra; A Buursma; W P Meeuwsen-van der Roest
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

4.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum.

Authors:  Jaime Prat
Journal:  Int J Gynaecol Obstet       Date:  2013-10-22       Impact factor: 3.561

5.  Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes.

Authors:  M D Scott; J J van den Berg; T Repka; P Rouyer-Fessard; R P Hebbel; Y Beuzard; B H Lubin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Identification of multiple pathways involved in the malignant transformation of endometriosis (Review).

Authors:  Yumi Higashiura; Hirotaka Kajihara; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2012-04-23       Impact factor: 2.967

7.  Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan.

Authors:  H Kobayashi; K Sumimoto; N Moniwa; M Imai; K Takakura; T Kuromaki; E Morioka; K Arisawa; T Terao
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

8.  Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosis-associated ovarian cancer.

Authors:  Henri Sova; Juha Kangas; Ulla Puistola; Markku Santala; Annikki Liakka; Peeter Karihtala
Journal:  Anticancer Res       Date:  2012-08       Impact factor: 2.480

Review 9.  The role of iron in the pathogenesis of endometriosis.

Authors:  Hiroshi Kobayashi; Yoshihiko Yamada; Seiji Kanayama; Naoto Furukawa; Taketoshi Noguchi; Shoji Haruta; Shozo Yoshida; Mariko Sakata; Toshiyuki Sado; Hidekazu Oi
Journal:  Gynecol Endocrinol       Date:  2009-01       Impact factor: 2.260

10.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more
  4 in total

1.  Macrophages Protect Endometriotic Cells Against Oxidative Damage Through a Cross-Talk Mechanism.

Authors:  Kenji Ogawa; Tingting Liu; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Reprod Sci       Date:  2022-02-23       Impact factor: 2.924

2.  Discrimination of malignant transformation from benign endometriosis using a near-infrared approach.

Authors:  Naoki Kawahara; Yuki Yamada; Fuminori Ito; Wataru Hojo; Takuya Iwabuchi; Hiroshi Kobayashi
Journal:  Exp Ther Med       Date:  2018-01-19       Impact factor: 2.447

3.  Validation of magnetic resonance relaxometry R2 value and cyst fluid iron level for diagnosis of ovarian endometrioma.

Authors:  Shogo Imanaka; Yuki Yamada; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Redox Rep       Date:  2021-12       Impact factor: 4.412

4.  A diagnostic challenge of seromucinous borderline tumor: A case report.

Authors:  Tingting Liu; Daichi Sumida; Takuya Wada; Tomoka Maehana; Aika Yamawaki; Sumire Sugimoto; Naoki Kawahara; Chiharu Yoshimoto; Hiroshi Kobayashi
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.